Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000226359 | SCV000288576 | benign | Wilms tumor 1 | 2023-12-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001572061 | SCV001796641 | likely benign | not provided | 2020-07-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002354657 | SCV002656078 | likely benign | Inborn genetic diseases | 2019-08-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002500784 | SCV002813760 | likely benign | Wilms tumor 1; Simpson-Golabi-Behmel syndrome type 1 | 2022-03-04 | criteria provided, single submitter | clinical testing |